Lumicell, Inc.
PrivateLast Round
Series D
Extension
Apr 22, 2025
Est. Valuation
$250M
Total Funding Raised
$202.05M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lumicell, Inc. is a medical device company that develops innovative fluorescence-guided surgical technologies to enable real-time detection and removal of residual cancerous tissue during surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumicell, Inc. Comparables
Compare Lumicell, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dilon Technologies Inc. | 84% | |
| KUBTEC Medical Imaging | 80% | |
| Clarix Imaging | 79% |
Lumicell, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Apr 22, 2025 | ||||
| Series D | Jul 11, 2024 | ||||
| Series C | Feb 22, 2024 | ||||
| Series D | Jul 26, 2023 | ||||
| Series D | May 25, 2021 | ||||
Debt | Apr 15, 2020 |
Lumicell, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Furneaux Capital | Series D |
| Kodiak Venture Partners | Series C |
| BlueIO | Series D, Series C |
| Massachusetts Life Sciences Center | Debt |
| Rivas Capital | Series D |
| Kinled Holding | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 59% MoM.
- Apr 1, 2026
Fluorescence-guided surgery platform is now a commercially approved Class III medical device.
Recent news
Latest coverage and updates
- expands_offices_inSep 15, 2026
Lumicell expanded offices in United States, Northern America, Americas on Sep 15th '26.
Lumicell, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lumicell, Inc.'s valuation, stock price, and market status.
Is Lumicell, Inc. a public or private company?
Lumicell, Inc. is a private company.
What is the current stock price of Lumicell, Inc.?
Lumicell, Inc. is a private company, so its shares have no public market price. Caplight tracks Lumicell, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lumicell, Inc. worth (valuation)?
Lumicell, Inc.'s valuation is estimated at $250.0M based on funding round data.
Can I buy Lumicell, Inc. stock?
Lumicell, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lumicell, Inc.'s last funding round?
Lumicell, Inc.'s most recent funding round was Series D Extension on April 22, 2025.
Who are the main investors in Lumicell, Inc.?
Key investors in Lumicell, Inc. include Launch Capital.
Will Lumicell, Inc. IPO soon?
No public IPO plans have been announced for Lumicell, Inc..
How can I track Lumicell, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lumicell, Inc.'s shares on secondary markets.